Leerink Partners Assumes Abbvie (ABBV) at Market Perform

Leerink Partners analyst Jeffrey La Rosa assumes coverage on Abbvie (NYSE: ABBV) with a Market Perform rating and a price target of $173.00.

For an analyst ratings summary and ratings history on Abbvie click here. For more ratings news on Abbvie click here.

Shares of Abbvie closed at $165.39 yesterday.

You May Also Be Interested In

• Wolfe Research Upgrades Abbvie (ABBV) to Outperform
• ICICI Securities Resumes Oberoi Realty Ltd (OBER:IN) at Buy (1)
• Raymond James Starts SpyGlass Pharma (SGP) at Outperform